Blog

High-throughput single B cell screening is transforming discovery. Biointron demonstrates how advanced platforms accelerate identification of potent antibodies.

Antibody humanization reduces immunogenicity and preserves specificity. Biointron highlights methods that transform murine antibodies into safe, effective therapies.

Isotype negative antibodies are essential controls. Biointron outlines their role in research, ensuring reliable data and validating experimental outcomes.

Antibody engineering optimizes performance. Biointron outlines methods to enhance affinity, stability, and developability, advancing therapeutic antibody success.

Innovative antibody formats like VHHs, scFvs, and ADCs expand therapeutic options. Biointron explores how these formats drive flexibility and efficacy.

Discover monoclonal antibodies (mAbs), their therapeutic roles in cancer, autoimmune, and infectious diseases, and their impact on modern medicine and research.

Explore the role of bispecific antibodies (bsAbs) in cancer therapy and beyond, and learn how dual-targeting enhances immune responses and overcomes monoclonal limits.

High-affinity antibodies improve therapy. Biointron reviews engineering strategies that increase binding strength, potency, and therapeutic performance.

Benchmark Positive Antibodies ensure reliable validation. Biointron explains their role in confirming assay accuracy and building trust in experimental results.

Antibodies are versatile research tools. Biointron highlights their applications in diagnostics, validation, and experimental discovery across biotechnology.

The 15th World Bispecifics Summit in Boston showcased breakthroughs. Biointron shares highlights shaping the future of bispecific antibody therapeutics.

FcRn is critical for IgG recycling and half-life extension. Biointron explores its biology and applications in designing durable therapeutic antibodies.